Loading clinical trials...
Loading clinical trials...
Tocilizumab in Chronic GVHD Refractory to at Least Two Prior Therapies
Conditions
Interventions
tocilizumab
laboratory biomarker analysis
+1 more
Locations
5
United States
Mayo Clinic Hospital
Phoenix, Arizona, United States
Mayo Clinic
Rochester, Minnesota, United States
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Seattle, Washington, United States
Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Start Date
February 1, 2016
Primary Completion Date
August 1, 2019
Last Updated
May 6, 2016
NCT01804686
NCT07356245
NCT04745221
NCT05866302
NCT06904599
NCT03924401
Lead Sponsor
Fred Hutchinson Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions